New eye drop aims to ease pain of retinal shots
NCT ID NCT05750589
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new eye drop called IRX-101 to see if it reduces pain and surface damage after anti-VEGF injections for retinal disease. About 240 adults who get these injections will receive either IRX-101 or standard povidone-iodine. The goal is to make the procedure more comfortable and protect the eye's surface.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINAL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
R. Gary Lane, II MD
San Antonio, Texas, 78240, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a smartphone camera spot blinding eye diseases?
- Could stem cells restore sight in damaged eyes?
- New eye scanner aims to sharpen view of retinal disease
- New eye camera could spot retinal disease earlier
- AI boosts eye Doctors' accuracy in reading retinal scans?
- Massive eye database aims to unlock secrets of blinding diseases